Intensive chemotherapy with hematopoietic cell transplantation after ESHAP therapy for relapsed or refractory non-Hodgkin's lymphoma. Results of a single-centre study of 65 patients

Leukemia and Lymphoma

Volumn 33, Issue 5-6, 1999, Pages 543-550

  Soussain, Carole ^a   Souleau, Bertrand ^a   Gabarre, Jean ^a   Zouabi, Hamadi ^a   Sutton, Laurent ^a   Boccaccio, Catherine ^a   Albin, Nicolas ^a   Charlotte, Frédéric ^a   Merle Béral, Hélène ^a   Delort, Josée ^a   Binet, Jacques Louis ^a   Leblond, Véronique ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

ESHAP chemotherapy; Intensive chemotherapy; NHL; Refractory; Relapsing lymphoma; Single centre; Stem cell transplantation

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE;

ADOLESCENT; ADULT; ARTICLE; CANCER SURVIVAL; DISEASE COURSE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; OTOTOXICITY; PNEUMONIA; PRIORITY JOURNAL; RELAPSE; REMISSION; SIDE EFFECT; TIME;

EID: 0032907686     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909058458     Document Type: Article

References (20)

1. Velasquez, W.S., McLaughlin, P., Tucker, S. et al (1994) ESHAP - an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. J. Clin. Oncol., 12, 1169-76.
2. Cabanillas, F. (1991) Experience with salvage regimens at M.D. Anderson Hospital. Annals of Oncology, 2, 31-32 (suppl. 1).
3. Collins, C., Mortimer, J., Livingstone, R.B. (19890 High-dose cyclophosphamide in the treatment of refractory lymphomas and solid tumor malignancies. Cancer, 63, 228-232.
4. Soiffier, S.J., Caliguiri, M.A., Tondin, C. (1989) High-dose cytosine arabinoside in relapsed and refractory non-Hodgkin's lymphoma. Cancer, 64, 2014-2018.
5. Cabanillas, F., Hagemeister, F.B., McLaughlin, P. et al (1987) Results of MIME salvage regimen for recurrent or refractory lymphoma. J. Clin. Oncol., 5, 407-12.
6. Eghbali, H., Catry, T.I., Soubeyran, P. et al (1994) Combination of etoposide, cisplatin and ifosfamide (VPH) in the salvage chemotherapy of relapsing or refractory aggressive malignant lymphoma.Study of 51 patients. Bull. Cancer, 81, 800-7.
7. Buzzoni, R., Colleoni, M., Bajetta, E. et al (1993) Effective salvage chemotherapy in relapsed or refractory non-Hodgkin's lymphoma. Annals. Oncol., 4, 251-3.
8. Matsuura, Y., Nakamura, H., Kogure, K. et al (1994) A combination chemotherapy of mitoxantrone, etoposide, carboplatin, and prednisolone (MECP) in recurrent or refractory non-Hodgkin's lymphomas. Jap. J. Cancer. Chemother., 21, 237-41.
9. Richardson, D.S., Tighe, M., Cull, G. et al (1994) Salvage chemotherapy for relapsed and resistant lymphoma with a carboplatin containing schedule - EPIC. Hematol. Oncol., 12, 125-128.
10. Okamoto, M., Maruyama, F., Tsuzuki, M. et al (1994) Salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphoma with a combination of dexamethasone, etoposide, ifosfamide and carboplatin. Rinsho Ketsueki, 35,635-41.
11. Ahmed, T., Cook, P., Feldman, E. et al (1994) Phase I-II trial of high dose Ara-C, carboplatinum, etoposide and steroids in patients with refractory or relapsed lymphomas. Leukemia, 8, 531-4.
12. Velasquez, W.S., Cabanillas, F., Salvador, P. et al (19889 Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP). Blood, 71, 117-122.
13. Press, O.W., Livingston, R., Mortimer, J. et al (1991) Treatment of relapsed non Hodgkin's lymphomas with dexamethasone, high-dose cytarabine, and cisplatin before marrow transplantation. J. Clin. Oncol., 9, 423-31.
14. Rodriguez, M.A., Cabanillas, F., Velasquez, W. (1995) Results of a salvage treatment program for relapsing lymphoma: MESNA-ifosfamide, novantrone, and etoposide (MINE), consolidated with etoposide, solumedrol, high-dose arabinoside and cisplatinum (ESHAP). J. Clin. Oncol., 13, 1734-1741.
15. Bosly, A., Coiffier, B., Gisselbrecht, C. et al (1992) Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen. J. Clin. Oncol., 10, 1615-23.
16. Philip, T., Armitage, J.O., Spitzer, G. et al (1987) High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non Hodgkin's lymphoma. New. Engl. J. Med., 316, 1493-1498.
17. Velasquez, W.S. (1995) ASHAP with or without ABMT for high-risk non Hodgkin's lymphoma (NHL). Proc. Am. Soc. Clin. Oncol., 14, 387 (abst).
18. Philip, T., Guglielmi, C, Hagenbeek, A. et al (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non Hodgkin's lymphoma. N Engl J Med. 333, 1540-1545.
19. Dreyfus, F., Leblond, V., Belanger, C. et al (1992) Peripheral blood stem cell collection and autografting in high risk lymphomas. Bone Marrow Transplant, 10, 409-413.
20. Bosly, A., Sonet, A., Salles, G. et al (1997) Superiority of late over early intensification in relapsing/refractory aggressive non Hodgkin's lymphoma: a randomized study from the GELA: LNH RP 93. Blood, 80, suppl 1: 2639 (abst).